NCT01686880

Y90 Radioembolization Prior to Surgical Resection or Radiofrequency for Hepatocellular Carcinoma in Cirrhotic Liver

Treatment With Yttrium90 Radioembolization Prior to Surgical Resection or Radiofrequency for Hepatocellular Carcinoma in Cirrhotic Liver

• Status: Terminated
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 10 (actual)
• Sponsor: Jules Bordet Institute · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to assess the safety of transarterial radioembolization prior to surgical resection or radiofrequency in cirrhotic patients with hepatocellular carcinoma

Detailed description

The purpose of this study is to assess the peri-operative morbidity and mortality of supraselective ablative transarterial radioembolization prior to surgical resection or radiofrequency in cirrhotic patients with HCC

Conditions

• Hepatocellular Carcinoma
• Liver Cirrhosis

Interventions

Type	Name	Description
DEVICE	Sirsphere trans-arterial radioembolization	Patients will receive Sirsphere trans-arterial radioembolization before surgery

Timeline

• Start date: 2012-09-01
• Primary completion: 2015-01-01
• Completion: 2015-01-01
• First posted: 2012-09-18
• Last updated: 2015-07-01

Locations

2 sites across 1 country: Belgium